CVS Health Reports Q4 and Full-Year 2025 Financial Results with Revenue Increase and Adjusted EPS Decline

Details

Despite the revenue growth, the company's GAAP diluted EPS increased to $2.30 from $1.30 in the prior year, while Adjusted EPS decreased slightly to $1.09 from $1.19 due to changes in the seasonality of the Medicare Part D program. The company also highlighted operational improvements across its segments, including increased pharmacy claims processed and prescriptions filled, and confirmed its full-year 2026 guidance.

Items reported

About CVS Health Corporation

CVS Health Corporation is a leading health services company in the United States, offering a comprehensive range of services aimed at improving healthcare accessibility and convenience. Primarily known for its extensive network of pharmacies, CVS Health operates thousands of retail locations nationwide. These outlets provide prescription medications, over-the-counter drugs, health and wellness products, and immunization services. Beyond retail, CVS Health plays a significant role in the healthcare sector through its pharmacy benefit management division, Caremark, which administers prescription drug plans for insurers and employers. Additionally, the company owns Aetna, a major health insurance provider, aligning its services across retail, pharmacy benefits, and insurance solutions to deliver integrated healthcare experiences. With its broad reach and diverse healthcare offerings, CVS Health Corporation holds a critical place in the healthcare market, continuously working to streamline and enhance the delivery of medical services across the country.